HUMA Therapeutics

Huma receives multi-condition US FDA 510(k) Class II regulatory clearance for its configurable SaMD disease management platform

by

Class II clearance expands the patient population that can be managed  Companies working with Huma’s platform can now launch algorithm innovations more quickly in a compliant and de-risked manner, democratising digital health innovation across the industry Clearance was granted through the FDA’s joint eSTAR programme which aims to increase the efficiency of regulation through digitalisation NEW YORK … Read more

Huma named for its successful and innovative approach to clinical trials in new UK government review

by

Huma’s innovative approach to medical research cited in Lord James O’Shaughnessy’s review for clinical trials improvement in the UK The review is part of a new widespread policy approach to ignite the UK’s life sciences sector Innovating clinical trials using digital technologies such as Huma’s platforms can make them more accessible, more diverse, faster to … Read more

Huma named for its successful and innovative approach to clinical trials in new UK government review

by

Huma’s innovative approach to medical research cited in Lord James O’Shaughnessy’s review for clinical trials improvement in the UK The review is part of a new widespread policy approach to ignite the UK’s life sciences sector Innovating clinical trials using digital technologies such as Huma’s platforms can make them more accessible, more diverse, faster to … Read more